Site Map

Arrhenoblastoma of ovary

Stromal tumor; Gonadal stromal tumor; Sex cord tumor; Androblastoma

Arrhenoblastoma of the ovary is an ovarian tumor that releases the male hormone, testosterone, or other hormones.

See also: Sertoli-Leydig cell tumor

I Would Like to Learn About:

Causes

This is a rare tumor. It accounts for less than 0.5% of all ovarian tumors.

These tumors are found in women of all age groups, but are most common in young women.

Symptoms

This tumor releases male hormones, which cause the following symptoms in women:

Exams and Tests

Treatment

Surgery to remove the tumor is the main treatment. If the cancer has spread, chemotherapy or radiation therapy may be considered.

Support Groups

You can ease the stress of illness by joining a support group where members share common experiences and problems. See cancer - support group.

Outlook (Prognosis)

The outcome of this disease depends on whether it has spread, and whether surgery can completely remove the tumor.

Arrhenoblastoma has a low chance of spreading. If the tumor is found early, the cure rate can be very good.

Possible Complications

When to Contact a Medical Professional

Call your health care provider if you are a woman and have masculine symptoms, or you feel a lump in your lower belly area.

Prevention

There is no good screening test. Regular gynecologic exams and recognizing masculine symptoms may help detect the disease.

Related Information

Ovarian cancer
Testosterone

References

Bulun SE, Adashi EY. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 17.

Coleman RL, Gershenson DM. Neoplastic diseases of the ovary: screening, benign and malignant epithelial and germ cell neoplasms, sex-cord stromal tumors. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, PA: Mosby Elsevier; 2007:chap 33.

BACK TO TOP

Review Date: 3/23/2014  

Reviewed By: Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2016 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com